Workup for Suspected Pemphigus Vulgaris
Obtain perilesional skin biopsies for both histology and direct immunofluorescence (DIF), and send serum for indirect immunofluorescence (IIF) and ELISA testing for desmoglein 1 and 3 antibodies—DIF remains the gold-standard diagnostic investigation. 1
Biopsy Protocol
For Cutaneous Disease
- Take two biopsies from perilesional skin:
- One for routine histology (looking for suprabasal acantholysis with blister formation)
- One for direct immunofluorescence (DIF)
- The DIF will show characteristic IgG and/or complement C3 deposition on keratinocyte cell surfaces in a "fishnet" pattern 1, 2
For Isolated Oral Disease
- Histology specimen: Take from perilesional mucosa
- DIF specimen: Take from uninvolved area, ideally from buccal mucosa 1
- This distinction is critical because oral pemphigus is often the initial presentation (80-90% of cases) and diagnostic delay is very common when confined to mucosa 3
Serological Testing
Send 5 mL of blood for both:
Indirect immunofluorescence (IIF): Less sensitive than DIF but helpful when biopsy is difficult (children, uncooperative adults) 1
ELISA for desmoglein antibodies:
- Measures desmoglein 1 and desmoglein 3 antibodies directly
- More sensitive than IIF
- Complementary to DIF, not a replacement 1
- The antibody profile determines clinical phenotype: desmoglein 3 alone typically causes mucosal disease, while both desmoglein 1 and 3 antibodies (50-60% of patients) cause mucocutaneous disease 1
Clinical Pitfalls to Avoid
Diagnostic anchoring is a major problem. Pemphigus is frequently misdiagnosed as candidiasis, herpes zoster, Behçet's disease, or bullous impetigo, leading to treatment delays that worsen outcomes 2, 4, 5. The similarity to more prevalent infectious and inflammatory diseases requires a high index of suspicion 5.
Do not rely on clinical appearance alone. While flaccid bullae and erosions are suggestive, histopathology and immunofluorescence are essential to distinguish PV from the broad range of mucocutaneous blistering disorders 3.
Do not delay biopsy in persistent mucocutaneous ulceration. If a patient with oral or skin blisters fails to respond to initial antimicrobial therapy, immediately obtain biopsies rather than trying additional empiric treatments 2, 5.
Why This Approach
DIF is the gold standard because it directly demonstrates the pathogenic autoantibodies bound to tissue, with near 100% sensitivity in active disease 1. The combination of DIF showing intercellular IgG/C3 deposition plus histology showing suprabasal acantholysis provides definitive diagnosis 1, 6. ELISA adds value by quantifying specific desmoglein antibodies, which helps predict disease phenotype and can be useful for monitoring, but cannot replace DIF since some patients have antibodies against other antigens 1.
Early diagnosis matters for mortality and morbidity—untreated PV had 75% mortality before corticosteroids, and mucocutaneous disease (8-42% mortality) is more severe than purely mucosal disease (1-17% mortality) 1. Diagnostic delay allows progression from oral-only to mucocutaneous disease, which is harder to treat and less likely to achieve remission 1.